v3.25.4
Income Taxes - Schedule of Net Deferred Tax Assets (Detail) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:        
Net operating loss carryforwards $ 167,203 $ 156,157    
Research and development tax credit carryforwards 54,149 54,648    
Section 174 capitalized research and development expenses 39,759 53,600    
Stock-based compensation expense 28,594 28,819    
Lease liability 22,689 23,917    
Contingent consideration 13,437 0    
Accrued expenses 1,788 7,032    
Section 163(j) limitation 1,843 5,599    
Depreciation and amortization 1,223 953    
Other 98 132    
Total deferred tax assets 330,783 330,857    
Deferred tax liabilities:        
Depreciation and amortization 0 0    
Right of use assets (19,822) (21,115)    
Total deferred tax liabilities (19,822) (21,115)    
Valuation allowance (310,961) (309,742) $ (312,809) $ (277,370)
Net deferred tax assets $ 0 $ 0